SmartMetric (SMME) S-1 23 May 22 IPO registration Financial data

Cover

Cover	9 Months Ended
	Mar. 31, 2022
Cover [Abstract]
Document Type	S-1
Amendment Flag	false
Entity Registrant Name	SmartMetric, inc.
Entity Central Index Key	0001301991
Entity Tax Identification Number	05-0543557
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	3960 Howard Hughes Parkway
Entity Address, Address Line Two	Suite 500
Entity Address, City or Town	Las Vegas
Entity Address, State or Province	NV
Entity Address, Postal Zip Code	89169
City Area Code	702
Local Phone Number	990-3687
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false

Consolidated Balance Sheet

Consolidated Balance Sheet - USD ($)	Jun. 30, 2021	Jun. 30, 2020
Current assets:
Cash	$ 10,325	$ 71,377
Prepaid expenses and other current assets	5,000	7,020
Total current assets	15,325	78,397
Non-current assets
Deferred financing costs	35,000	35,000
Total assets	50,325	113,397
Current liabilities:
Accounts payable and accrued expenses	1,073,786	916,728
Liability for stock to be issued	127,321	50,000
Deferred Officer’s salary	737,642	759,948
Related party interest payable	201,846	149,481
Dividends payable	2,442	2,945
Due to shareholders	41,343	41,343
Covid19 SBA loan	41,664	20,832
Convertible note payable, net of discount	35,000	32,127
Derivative liability	45,524
Convertible interest payable	3,801
Interest payable	875
Shareholder loan
Total current liabilities	2,331,244	1,973,404
Series C mandatory redeemable convertible preferred stock, net of discount, authorized 1000,000 shares, 239,025 and 117,200 shares issued and outstanding, respectively	196,083	101,661
Stockholders’ deficit:
Preferred stock, $.001 par value; 5,000,000 shares authorized, 610,000 and 610,000 shares issued and outstanding	610	610
Class A Preferred stock, $.001 par value; 50,000,000 shares authorized 0 and 0 shares issued and outstanding Common stock, $.001 par value; 600,000,000 shares authorized, 446,385,628 and 379,523,000 shares issued and outstanding, respectively	446,386	379,524
Additional paid-in capital	25,955,367	25,429,261
Accumulated deficit	(28,859,365)	(27,771,062)
Total stockholders’ deficit	(2,457,002)	(1,961,668)
Total liabilities and stockholders’ deficit	$ 50,325	$ 113,397

Consolidated Balance Sheet (Par

Consolidated Balance Sheet (Parenthetical) - $ / shares	Jun. 30, 2021	Jun. 30, 2020
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	610,000	610,000
Preferred stock, outstanding	610,000	610,000
Preferred stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Common stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	1,200,000,000	600,000,000
Common stock, issued	446,385,628	379,523,000
Common stock, outstanding	446,385,628	379,523,000
Series C Mandatory Redeemable Convertible Preferred Stocks [Member]
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	239,025	117,200
Preferred stock, outstanding	239,025	117,200
Preferred Class A [Member]
Preferred stock, shares authorized	50,000,000	50,000,000
Preferred stock, shares issued	0	0
Preferred stock, outstanding	0	0
Preferred stock, par value (in Dollars per share)	$ 0.001	$ 0.001

Consolidated Statements Of Oper

Consolidated Statements Of Operations - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021	Jun. 30, 2021	Jun. 30, 2020
Income Statement [Abstract]
Revenues
Expenses:
Officer’s salary	47,500	47,500	142,500	142,500	190,000	190,000
Other general and administrative	192,151	134,903	951,636	421,606	555,480	468,238
Research and development	44,551	16,822	113,446	60,761	76,344	89,240
Total operating expenses	284,202	199,225	1,207,582	624,867	821,824	747,478
Loss from operations before income taxes	(284,202)	(199,225)	(1,207,582)	(624,867)	(821,824)	(747,478)
Interest & Financing Expense	(22,673)	(13,897)	(102,300)	(45,879)	(59,914)	(58,099)
Gain (loss) on change in derivatives	326,919		(110,449)	(62,465)	(42,990)
Net loss	20,044	(213,122)	(1,399,499)	(733,211)	(924,728)	(805,577)
Preferred stock dividends	(5,787)		(10,589)	(163,575)	(163,575)	(32,024)
Net loss available for common stockholders	$ 14,257	$ (213,122)	$ (1,410,088)	$ (896,786)	$ (1,088,303)	$ (837,601)
Net loss per share, basic and diluted	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0
Weighted average number of common shares outstanding, basic and diluted	561,587,017	426,484,097	523,201,661	403,759,231	413,974,288	299,094,207

Consolidated Statements of Chan

Consolidated Statements of Changes In Stockholders' Equity (Deficit) - USD ($)	Preferred Series C Stock [Member]	Class A Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Jun. 30, 2019	$ 610		$ 264,649	$ 24,663,528	$ (26,933,461)	$ (2,004,674)
Balance (in Shares) at Jun. 30, 2019	610,000		264,648,821
Shares issued of common stock and warrants for cash			$ 97,584	576,703		674,287
Shares issued of common stock and warrants for cash (in Shares)			97,584,162
Preferred C shares Converted to Common			$ 17,240	182,580		199,820
Preferred C shares Converted to Common (in Shares)			17,240,017
Beneficial conversion feature related to convertible debt				5,000		5,000
Series C dividends					(32,024)	(32,024)
Shares of Common  Stock issued for services			$ 50	1,450		1,500
Shares of Common Stock issued for services (in Shares)			50,000
Net loss for period					(805,577)	(805,577)
Ending balance, value at Jun. 30, 2020	$ 610		$ 379,523	25,429,261	(27,771,062)	(1,966,668)
Balance (in Shares) at Jun. 30, 2020	610,000		379,523,000
Preferred C shares Converted to Common			$ 5,447	31,921		37,368
Beneficial conversion feature related to convertible debt
Series C dividends					(4,029)	(4,029)
Shares of Common  Stock issued for services			585	2,340		2,925
Net loss for period					(221,907)	$ (221,907)
Common shares issued for services (in Shares)						585,000
Balance (in Shares) at Sep. 30, 2020	610,000		385,555,260
Beginning balance, value at Jun. 30, 2020	$ 610		$ 379,523	25,429,261	(27,771,062)	$ (1,966,668)
Balance (in Shares) at Jun. 30, 2020	610,000		379,523,000
Shares issued of common stock and warrants for cash			$ 32,500	130,000		162,500
Shares issued of common stock and warrants for cash (in Shares)			32,500,000
Net loss for period					(924,728)	(924,728)
Common shares issued for services			$ 3,145	15,780		18,925
Common shares issued for services (in Shares)			3,145,440
Shares converted from Preferred C shares to common			$ 31,218	172,149		203,367
Shares converted from Preferred C shares to common (in Shares)			31,217,188
Valuation of Preferred C & derivative liability				208,177		208,177
Preferred C dividends					(163,575)	(163,575)
Ending balance, value at Jun. 30, 2021	$ 610		$ 446,386	25,955,367	(28,859,365)	(2,457,002)
Balance (in Shares) at Jun. 30, 2021	610,000		446,385,628
Balance (in Shares) at Sep. 30, 2020	610,000		385,555,260
Preferred C shares Converted to Common			$ 16,035	54,965		71,000
Net loss for period					(345,183)	(345,183)
Valuation of Preferred C & derivative liability				208,177		208,177
Balance (in Shares) at Dec. 31, 2020	610,000		416,590,136
Preferred C shares Converted to Common			$ 6,709	58,291		65,000
Net loss for period					(213,122)	(213,122)
Valuation of Preferred C & derivative liability
Balance (in Shares) at Mar. 31, 2021	610,000		443,359,676
Balance (in Shares) at Jun. 30, 2021	610,000		446,385,628
Net loss for period					(1,100,661)	(1,100,661)
Common shares issued for services			$ 4,095	31,905		36,000
Common shares issued for services (in Shares)			4,095,238
Shares converted from Preferred C shares to common			$ 17,535	89,466		107,001
Preferred C dividends					(1,423)	(1,423)
Balance (in Shares) at Sep. 30, 2021	610,000		488,648,586
Net loss for period					(318,882)	(318,882)
Common shares issued for services			$ 7,981	16,327		24,308
Common shares issued for services (in Shares)			7,981,455
Shares converted from Preferred C shares to common			$ 19,148	87,852		107,000
Preferred C dividends					(3,379)	(3,379)
Balance (in Shares) at Dec. 31, 2021	610,000		539,310,756
Net loss for period					20,044	20,044
Common shares issued for services			$ 3,714	21,286		25,000
Common shares issued for services (in Shares)			3,714,286
Shares converted from Preferred C shares to common			$ 15,827	66,673		82,500
Preferred C dividends					$ (5,787)	(5,787)
Ending balance, value at Mar. 31, 2022						$ (2,191,456)
Balance (in Shares) at Mar. 31, 2022	610,000		616,351,592

Consolidated Statements Of Cash

Consolidated Statements Of Cash Flows - USD ($)	12 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (924,728)	$ (805,577)
Adjustments to reconcile net loss to net cash used in operating activities:
Common stock issued and issuable for services	18,926	1,500
Non cash financing expense	49,322
Gain (loss) on fair value of derivative liability	112,565
Amortization of debt discount	2,873	2,127
Changes in assets and liabilities
Increase (Decrease) in prepaid expenses and other current assets	2,017	(567)
Increase in accounts payable and accrued expenses	157,058	32,588
(Decrease) in deferred officer salary	(22,306)	(30,067)
Increase in Convertible interest payable	3,801
Increase in accrued interest payable	52,365	55,993
Net cash used in operating activities	(567,582)	(744,003)
CASH FLOWS FROM FINANCING ACTIVITIES
Loans from related parties		(3,759)
Proceeds from notes payable		35,000
Deferred financing costs		(35,000)
Proceeds from sale of common stock	240,698	576,803
Proceeds from CARES Act PPP loan	20,832	20,832
Due to shareholder		41,343
Proceeds from sale of Series C Preferred stock	245,000	170,000
Net cash provided by financing activities	506,530	805,219
CASH	(61,052)	61,216
CASH BEGINNING OF PERIOD	71,377	10,161
END OF PERIOD	10,325	71,377
Non-cash investing and financing activities	66,000	191,636
Conversion of 72,600 & 104,000 Preferred C Shares into 21,482,136 & 5,595,339 shares of common stock
CASH PAID DURING THE PERIOD FOR:
Income taxes
Interest

Consolidated Statements Of Ca_2

Consolidated Statements Of Cash Flows (Parenthetical) - shares	3 Months Ended					9 Months Ended		12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Dec. 31, 2019	Mar. 31, 2022	Mar. 31, 2021	Jun. 30, 2021	Jun. 30, 2020
Conversion of shares	90,750	19,148,052	17,534,387
Common Stock [Member]
Number of shares issued						34,974,602	21,482,136	21,482,136	5,595,339
Series C Preferred Stock [Member]
Conversion of shares				36,300	36,300	216,425	72,600	72,600	104,000

Condensed Consoldated Balance S

Condensed Consoldated Balance Sheet (Unaudited) - USD ($)	Mar. 31, 2022	Jun. 30, 2021
Current assets:
Cash	$ 306,730	$ 10,325
Prepaid expenses and other current assets	20,470	5,000
Total current assets	327,200	15,325
Non-current assets
Deferred financing costs	35,000	35,000
Total assets	362,200	50,325
Current liabilities:
Accounts payable and accrued expenses	1,047,196	1,073,786
Liability for stock to be issued	127,665	127,321
Deferred Officer’s salary	753,475	737,642
Related party interest payable	240,712	201,846
Dividends payable	10,589	2,442
Due to shareholders	49,630	41,343
Covid19 SBA loan	20,832	41,664
Convertible note payable, net of discount	35,000	35,000
Derivative liability	155,973	45,524
Convertible interest payable	7,249	3,801
Interest payable	1,750	875
Total current liabilities	2,450,072	2,311,244
Series C mandatory redeemable convertible preferred stock, net of discount, authorized 1000,000 shares, 146,084 and 239,025 shares issued and outstanding, respectively	103,584	196,083
Stockholders’ deficit:
Preferred stock, $.001 par value; 5,000,000 shares authorized, 610,000 and 610,000 shares issued and outstanding	610	610
Common stock, $.001 par value; 1,200,000,000 shares authorized, 616,351,592 and 446,385,628 shares issued and outstanding, respectively	616,352	446,386
Additional paid-in capital	27,461,035	25,955,367
Accumulated deficit	(30,269,453)	(28,859,365)
Total stockholders’ deficit	(2,191,456)	(2,457,002)
Total liabilities and stockholders’ deficit	$ 362,200	$ 50,325

Condensed Consoldated Balance_2

Condensed Consoldated Balance Sheet (Unaudited) (Parenthetical) - $ / shares	Mar. 31, 2022	Jun. 30, 2021
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	610,000	610,000
Preferred stock, shares outstanding	610,000	610,000
Preferred stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Common stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	1,200,000,000	1,200,000,000
Common stock, shares issued	616,351,592	446,385,628
Common stock, shares outstanding	616,351,592	446,385,628
Series C Redeemable Convertible Preferred Stock [Member]
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	146,084	239,025
Preferred stock, shares outstanding	146,084	239,025
Class A Preferred Stock [Member]
Preferred stock, shares authorized	50,000,000	50,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Preferred stock, par value (in Dollars per share)	$ 0.001	$ 0.001

Condensed Consoldated Statement

Condensed Consoldated Statements Of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Income Statement [Abstract]
Revenues
Expenses:
Officer’s salary	47,500	47,500	142,500	142,500
Other general and administrative	192,151	134,903	951,636	421,606
Research and development	44,551	16,822	113,446	60,761
Total operating expenses	284,202	199,225	1,207,582	624,867
Loss from operations before income taxes	(284,202)	(199,225)	(1,207,582)	(624,867)
Interest & Financing Expense	(22,673)	(13,897)	(102,300)	(45,879)
Gain on PPP loan forgiveness			20,832
Gain (loss) on change in derivatives	326,919		(110,449)	(62,465)
Total other income (expenses)	304,246	(13,897)	(191,917)	(108,344)
Net loss	20,044	(213,122)	(1,399,499)	(733,211)
Preferred stock dividends	(5,787)		(10,589)	(163,575)
Net loss available for common stockholders	$ 14,257	$ (213,122)	$ (1,410,088)	$ (896,786)
Net loss per share, basic and diluted	$ 0	$ 0	$ 0	$ 0
Weighted average number of common shares outstanding, basic and diluted	561,587,017	426,484,097	523,201,661	403,759,231

Consoldated Statements of Chang

Consoldated Statements of Changes In Stockholders' Equity (Deficit) (Unaudited) - USD ($)	Preferred Series C Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance (in Shares) at Jun. 30, 2019	610,000	264,648,821
Preferred C shares Converted to Common		$ 17,240	$ 182,580		$ 199,820
Beneficial conversion feature related to convertible debt			5,000		5,000
Series C dividends				(32,024)	(32,024)
Shares of Common Stock issued for services		50	1,450		1,500
Net income for period				(805,577)	(805,577)
Ending balance, value at Jun. 30, 2020	$ 610	$ 379,523	25,429,261	(27,771,062)	$ (1,961,671)
Balance (in Shares) at Jun. 30, 2020	610,000	379,523,000
Common shares issued for services, Shares					585,000
Shares issued of common stock for warrants and cash
Preferred C shares Converted to Common		$ 5,447	31,921		37,368
Preferred C shares Converted to Common, Shares		5,447,260
Beneficial conversion feature related to convertible debt
Series C dividends				(4,029)	(4,029)
Shares of Common Stock issued for services		$ 585	2,340		2,925
Shares of Common Stock issued for services, Shares		585,000
Net income for period				(221,907)	(221,907)
Ending balance, value at Sep. 30, 2020	$ 610	$ 385,555	25,463,522	(27,996,998)	(2,147,312)
Balance (in Shares) at Sep. 30, 2020	610,000	385,555,260
Beginning balance, value at Jun. 30, 2020	$ 610	$ 379,523	25,429,261	(27,771,062)	(1,961,671)
Balance (in Shares) at Jun. 30, 2020	610,000	379,523,000
Common shares issued for services		$ 3,145	15,780		18,925
Common shares issued for services, Shares		3,145,440
Shares converted from Preferred C shares to common		$ 31,218	172,149		203,367
Preferred C dividends				(163,575)	(163,575)
Valuation of Preferred C and derivative liability			208,177		208,177
Net income for period				(924,728)	(924,728)
Ending balance, value at Jun. 30, 2021	$ 610	$ 446,386	25,955,367	(28,859,365)	(2,457,002)
Balance (in Shares) at Jun. 30, 2021	610,000	446,385,628
Beginning balance, value at Sep. 30, 2020	$ 610	$ 385,555	25,463,522	(27,996,998)	(2,147,312)
Balance (in Shares) at Sep. 30, 2020	610,000	385,555,260
Shares issued of common stock for warrants and cash		$ 15,000	60,000		75,000
Shares issued of common stock for warrants and cash, Shares		15,000,000
Preferred C shares Converted to Common		$ 16,035	54,965		71,000
Preferred C shares Converted to Common, Shares		16,034,876
Valuation of Preferred C and derivative liability			208,177		208,177
Series C Preferred Dividends				(112,547)	(112,547)
Net income for period				(345,183)	(345,183)
Ending balance, value at Dec. 31, 2020	$ 610	$ 416,590	25,786,662	(28,454,728)	(2,250,865)
Balance (in Shares) at Dec. 31, 2020	610,000	416,590,136
Shares issued of common stock for warrants and cash		$ 17,500	70,000		87,500
Shares issued of common stock for warrants and cash, Shares		17,500,000
Preferred C shares Converted to Common		$ 6,709	58,291		65,000
Preferred C shares Converted to Common, Shares		6,709,100
Valuation of Preferred C and derivative liability
Series C Preferred Dividends
Net income for period				(213,122)	(213,122)
Shares issued of common stock for services		$ 2,560	13,440		16,000
Shares issued of common stock for services, Shares		2,560,440
Ending balance, value at Mar. 31, 2021	$ 610	$ 443,359	25,928,391	(28,667,850)	(2,295,487)
Balance (in Shares) at Mar. 31, 2021	610,000	443,359,676
Beginning balance, value at Jun. 30, 2021	$ 610	$ 446,386	25,955,367	(28,859,365)	(2,457,002)
Balance (in Shares) at Jun. 30, 2021	610,000	446,385,628
Common shares issued for services		$ 4,095	31,905		36,000
Common shares issued for services, Shares		4,095,238
Shares issued of common stock and warrants for cash		$ 8,133	59,367		67,500
Shares issued of common stock and warrants for cash, Shares		8,133,333
Shares converted from Preferred C shares to common		$ 17,535	89,466		107,001
Shares converted from Preferred C shares to common, Shares		17,534,387
Shares issued for finder's fee		$ 12,500	237,500		250,000
Shares issued for finder's fee, Shares		12,500,000
Preferred C dividends				(1,423)	(1,423)
Net income for period				(1,100,661)	(1,100,661)
Ending balance, value at Sep. 30, 2021	$ 610	$ 488,649	26,373,605	(29,961,449)	(3,098,585)
Balance (in Shares) at Sep. 30, 2021	610,000	488,648,586
Common shares issued for services		$ 7,981	16,327		24,308
Common shares issued for services, Shares		7,981,455
Common shares issued for AJB finder's fee		$ 12,500	112,500		125,000
Common shares issued for AJB finder's fee, shares		12,500,000
Shares issued of common stock and warrants for cash		$ 11,033	57,294		68,327
Shares issued of common stock and warrants for cash, Shares		11,032,663
Shares converted from Preferred C shares to common		$ 19,148	87,852		107,000
Shares converted from Preferred C shares to common, Shares		19,148,052
Preferred C dividends				(3,379)	(3,379)
Net income for period				(318,882)	(318,882)
Ending balance, value at Dec. 31, 2021	$ 610	$ 539,311	26,647,576	(30,283,710)	(3,096,213)
Balance (in Shares) at Dec. 31, 2021	610,000	539,310,756
Common shares issued for services		$ 3,714	21,286		25,000
Common shares issued for services, Shares		3,714,286
Shares issued of common stock and warrants for cash		$ 57,500	725,500		783,000
Shares issued of common stock and warrants for cash, Shares		57,500,000
Shares converted from Preferred C shares to common		$ 15,827	66,673		82,500
Shares converted from Preferred C shares to common, Shares		15,826,550
Preferred C dividends				(5,787)	(5,787)
Net income for period				20,044	20,044
Ending balance, value at Mar. 31, 2022	$ 610	$ 616,352	$ 27,461,035	$ (30,269,453)	$ (2,191,456)
Balance (in Shares) at Mar. 31, 2022	610,000	616,351,592

Condensed Consolidated Statemen

Condensed Consolidated Statement Of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (1,399,499)	$ (733,211)
Adjustments to reconcile net loss to net cash used in operating activities:
Common stock issued and issuable for services	460,306	18,926
Non cash financing expense		49,322
Gain (loss) on fair value of derivative liability	110,449	112,565
Gain on PPP loan forgiveness	(20,832)
Amortization of debt discount	30,000	2,873
Changes in assets and liabilities
Increase (Decrease) in prepaid expenses and other current assets	(15,470)	(1,566)
Increase in accounts payable and accrued expenses	(33,380)	98,298
(Decrease) in deferred officer salary	15,833	(15,833)
Increase in Due to shareholder
Increase in Convertible interest payable	875	3,801
Increase in accrued interest payable	38,866	39,205
Net cash used in operating activities	(812,852)	(425,620)
CASH FLOWS FROM FINANCING ACTIVITIES
Loans from related parties		(2,817)
Proceeds from sale of common stock	938,827	219,822
Proceeds from AJB Note	270,000
Repayment of AJB Note	(302,717)
Proceeds from sale of Series C Preferred stock	195,000	138,000
Proceeds from note - Barry
Change in dividends payable	8,147
Proceeds from PPP loan		20,832
Net cash provided by financing activities	1,109,257	375,837
CASH	296,405	(49,783)
CASH BEGINNING OF PERIOD	10,325	71,377
END OF PERIOD	306,730	21,594
Non-cash investing and financing activities	43,750	66,000
CASH PAID DURING THE PERIOD FOR:
Income taxes
Interest

Condensed Consolidated Statem_2

Condensed Consolidated Statement Of Cash Flows (Unaudited) (Parenthetical) - shares	3 Months Ended					9 Months Ended		12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Dec. 31, 2019	Mar. 31, 2022	Mar. 31, 2021	Jun. 30, 2021	Jun. 30, 2020
Conversion of shares	90,750	19,148,052	17,534,387
Common Stock [Member]
Number of shares issued						34,974,602	21,482,136	21,482,136	5,595,339
Series C Preferred Stock [Member]
Conversion of shares				36,300	36,300	216,425	72,600	72,600	104,000

ORGANIZATION AND BASIS OF PRESE

ORGANIZATION AND BASIS OF PRESENTATION	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND BASIS OF PRESENTATION	NOTE 1 ORGANIZATION AND BASIS OF PRESENTATION SmartMetric, Inc. (the “Company” or “SmartMetric”) was incorporated in the State of Nevada on December 18, 2002. SmartMetric’s main product is a fingerprint sensor-activated card with a finger sensor onboard the card and a built-in rechargeable battery for portable biometric identification. This card may be referred to as a biometric card or the SmartMetric Biometric card. SmartMetric has completed development of its card along with pre-mass manufacturing cards but has not yet begun to mass manufacture the biometric fingerprint activated cards. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management of the Company, the accompanying unaudited financial statements contain all the adjustments (which are of a normal recurring nature) necessary for a fair presentation. Operating results for the three and nine months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the year ending June 30, 2022. For further information, refer to the financial statements and the footnotes thereto contained in the Company’s Annual Report on Form 10-K for the year ended June 30, 2021, as filed with the Securities and Exchange Commission on October 12, 2021. The consolidated balance sheet as of June 30, 2021, has been derived from the audited financial statements at that date, but does not include all the information and footnotes required by US GAAP for complete financial statements. Going Concern As shown in the accompanying condensed consolidated financial statements the Company has sustained recurring losses of $ 1,399,499 30,269,453 These conditions raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date of this filing. The financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. COVID-19 has had an impact on SmartMetric’s final card production. While the delays are due to supply line disruption, the Company is confident that these delays will be short-lived based on advice from our manufacturing partners, manufacturing alternatives and alternative supply lines that are being put into place by the Company. Management believes that the Company’s capital requirements will depend on many factors. These factors include product marketing and distribution. The management plans include equity sales and borrowing in order to fund the operations. There are no assurances that the Company will be able to achieve the level of revenues adequate to generate sufficient cash flow from operations to support the Company’s working capital requirements. To the extent that funds generated are insufficient, the Company will have to raise additional working capital. No assurance can be given that additional financing will be available, or if available, will be on terms acceptable to the Company. If adequate working capital is not available, the Company may not continue its operations. In December 2019, an outbreak of a novel strain of coronavirus originated in Wuhan, China (“COVID-19”) and has since spread worldwide, including to the Unites States, posing public health risks that have reached pandemic proportions (the “COVID-19 Pandemic”). The COVID-19 Pandemic poses a threat to the health and economic wellbeing of our employees, customers and vendors. Like most businesses world-wide, the COVID-19 Pandemic has impacted the Company financially delaying the beginning of production. Principles of Consolidation The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, SmartMetric Australia Pty. Ltd. All significant intercompany accounts and transactions have been eliminated in consolidation.	NOTE 1 - ORGANIZATION AND BASIS OF PRESENTATION SmartMetric, Inc. (the “Company” or “SmartMetric”) was incorporated in the State of Nevada on December 18, 2002. SmartMetric’s main product is a fingerprint sensor-activated card with a finger sensor onboard the card and a built-in rechargeable battery for portable biometric identification. This card may be referred to as a biometric card or the SmartMetric Biometric Datacard. SmartMetric has completed development of its card along with pre-mass manufacturing cards but has not yet begun to mass manufacture the biometric fingerprint activated cards. Basis of Presentation The financial statements present the balance sheets, statements of operations, stockholder’s equity (deficit) and cash flows of the Company. The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America. The Company has adopted June 30 as its fiscal year end. Going Concern As shown in the accompanying condensed consolidated financial statements the Company has sustained recurring losses of $ 924,728 805,577 28,859,365 These conditions raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date of this filing. The financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. The COVID-19 has had an impact on SmartMetric’s final card production. While the delays are due to supply line disruption, the Company is confident that these delays will be short-lived based on advice from our manufacturing partners, manufacturing alternatives and alternative supply lines that are being put into place by the Company. Management believes that the Company’s capital requirements will depend on many factors. These factors include product marketing and distribution. The management plans include equity sales and borrowing in order to fund the operations. The Company plans to continue its relationship with Geneva Roth Remark in order to raise capital through means other than private placement stock sales. There are no assurances that the Company will be able to achieve the level of revenues adequate to generate sufficient cash flow from operations to support the Company’s working capital requirements. To the extent that funds generated are insufficient, the Company will have to raise additional working capital. No assurance can be given that additional financing will be available, or if available, will be on terms acceptable to the Company. If adequate working capital is not available, the Company may not continue its operations. On March 5, 2020, the Company entered into an agreement with GHS Investments, LLC whereas the investor agrees to invest up to four million dollar ($ 4,000,000 In December 2019, an outbreak of a novel strain of coronavirus originated in Wuhan, China (“COVID-19”) and has since spread worldwide, including to the Unites States, posing public health risks that have reached pandemic proportions (the “COVID-19 Pandemic”). The COVID-19 Pandemic poses a threat to the health and economic wellbeing of our employees, customers and vendors. Like most businesses world-wide, the COVID-19 Pandemic has impacted the Company financially; delaying the beginning of production.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2021
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, the Company evaluates its estimates, including, but not limited to, those related to income taxes and contingencies. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Research and Development Research and development costs are charged to expense as incurred. Our research and development expenses consist primarily of expenditures for electronics design and engineering, software design and engineering, component sourcing, component engineering, manufacturing, product trials, compensation and consulting costs. Recent Accounting Pronouncements The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position or cash flow. Loss Per Share of Common Stock In accordance with FASB ASC 260, “Earnings Per Share,” the basic loss per share is computed by dividing the loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. Basic net loss per share excludes the dilutive effect of stock options or warrants and convertible notes. Diluted net earnings (loss) per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents, consisting of shares that might be issued upon exercise of common stock options and warrants. In periods where losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of March 31, 2022 and 2021, 54,664,518 126,628,519 Stock-Based Compensation The Company records stock-based compensation in accordance with ASC 718, Compensation – Stock Compensation Equity-Based Payments to Non-Employees Fair value of financial instruments The Company measures fair value in accordance with ASC 820 - Fair Value Measurements. ASC 820 defines fair value and establishes a three-level valuation hierarchy for disclosures of fair value measurements. ASC 820 establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, ASC 820 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three (3) levels of fair value hierarchy defined by ASC 820 are: Level 1 Level 2 Level 3 As defined by ASC 820, the fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced or liquidation sale, which was further clarified as the price that would be received to sell an asset or paid to transfer a liability (“an exit price”) in an orderly transaction between market participants at the measurement date. The reported fair values for financial instruments that use Level 2 and Level 3 inputs to determine fair value are based on a variety of factors and assumptions. Accordingly, certain fair values may not represent actual values of the Company’s financial instruments that could have been realized as of March 31, 2022 or that will be recognized in the future, and do not include expenses that could be incurred in an actual settlement. The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts receivable, receivables from related parties, prepaid expenses and other, accounts payable, accrued liabilities, and related party and third-party notes payables approximate fair value due to their relatively short maturities. The Company’s notes payable to related parties approximates the fair value of such instrument based upon management’s best estimate of terms that would be available to the Company for similar financial arrangements at March 31, 2022.	NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Recent Accounting Pronouncements The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position or cash flow except as noted below. In February 2016, the FASB issued authoritative guidance ASC 842, “Leases.” This guidance requires lessees to recognize most leases on the balance sheet by recording a right-of-use asset and a lease liability. The Company has made the decision to adopt this guidance early, and it was adopted by the Company as of March 1, 2019. Based on the completed analysis, the Company has determined that the adjustment did not have a material impact on the financial statements. In June 2018, the FASB issued ASU 2018-07, Compensation—Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting, which aligns accounting for share-based payments issued to nonemployees to that of employees under the existing guidance of Topic 718, with certain exceptions. This update supersedes previous guidance for equity-based payments to nonemployees under Subtopic 505-50, Equity—Equity-Based Payments to Non-Employees. This guidance was adopted by the Company as of March 1, 2019. Based on the completed analysis, the Company has determined the adjustment did not have a material impact on the financial statements. Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, SmartMetric Australia Pty. Ltd. All significant intercompany accounts and transactions have been eliminated in consolidation. Fair Value of Financial Instruments The carrying amounts reflected in the balance sheets for cash, accounts payable and related party payables approximate the respective fair values due to the short maturities of these items. As required by the Fair Value Measurements and Disclosures Topic of the FASB ASC, fair value is measured based on a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: (Level 1) observable inputs such as quoted prices in active markets; (Level 2) inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and (Level 3) unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. The three levels of the fair value hierarchy are described below: Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities; Level 2: Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability; Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity). The Company at present does not have any Level 2 or Level 3 fair value instruments. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, the Company evaluates its estimates, including, but not limited to, those related to income taxes and contingencies. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Cash The Company considers all highly liquid debt instruments and other short-term investments with an initial maturity of three months or less to be cash equivalents. Any amounts of cash in financial institutions which exceed FDIC insured limits exposes the Company to cash concentration risk. The Company had no Research and Development Research and development costs are charged to expense as incurred. Our research and development expenses consist primarily of expenditures for electronics design and engineering, software design and engineering, component sourcing, component engineering, manufacturing, product trials, compensation and consulting costs. Revenue Recognition The Company has not recognized revenues to date. Therefore, the Company has not yet adopted a revenue recognition policy. Reclassifications Certain prior year amounts have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the reported results of operations. Uncertainty in Income Taxes GAAP requires the recognition and measurement of uncertain income tax positions using a “more-likely-than-not” approach. Management evaluates Company tax positions on an annual basis and has determined that as of June 30, 2021 and 2020, no accrual for uncertain income tax positions is necessary. Loss Per Share of Common Stock In accordance with FASB ASC 260, “Earnings Per Share,” the basic loss per share is computed by dividing the loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. Basic net loss per share excludes the dilutive effect of stock options or warrants and convertible notes. Diluted net earnings (loss) per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents, consisting of shares that might be issued upon exercise of common stock options and warrants. In periods where losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of June 30, 2021 and 2020, 124,888,519 53,280,406

PREPAID EXPENSES

PREPAID EXPENSES	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2021
Prepaid Expenses
PREPAID EXPENSES	NOTE 3 PREPAID EXPENSES Prepaid expenses represent the unexpired terms of various consulting agreements as well as advance rental payments. Prepaid expenses at March 31, 2022 were $ 20,470	NOTE 3 - PREPAID EXPENSES Prepaid expenses were $ 5,000

COMMITMENTS

COMMITMENTS	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS	NOTE 4 - COMMITMENTS AND CONTINGENCIES Lease Agreement The Company’s main office is in Las Vegas, Nevada. Rent expense under all leases for the three months ended March 31, 2022 and 2021 was $ 1,537 1,590 Related Party Transactions As of March 31, 2022 and 2021, the Company has accrued the amounts of $ 753,475 744,115 As a result of shareholder loans and deferred officer salary, the Company has accrued a balance of $ 240,712 188,686 On September 11, 2017, we received a license to certain patents from Chaya Hendrick, our founder and CEO, related to our technologies until the expiration of the patents. As consideration, we issued Chaya Hendrick, or her assigns, (i) 200,000 shares of Series B Convertible Preferred Stock, (ii) a royalty equal to 5% of gross revenues derived from products sold related to the patents, and (iii) certain minimum required payments beginning at $50,000 and doubling each year thereafter. The Series B Preferred Stock may be converted at the election of holder on a basis for 50 common shares for each preferred share at any time or an aggregate of 10,000,000 common shares in exchange for all 200,000 shares of Series B Convertible Preferred Stock. Our CEO maintains an employment agreement that stipulates a $ 190,000 Litigation From time to time we may be a defendant or plaintiff in various legal proceedings arising in the normal course of our business. As of the date of this Quarterly Report, there are no material pending legal or governmental proceedings relating to us or properties to which we are a party, and, to our knowledge, there are no material proceedings to which any of our directors, executive officers or affiliates are a party adverse to us or which have a material interest adverse to us.	NOTE 4 - COMMITMENTS Lease Agreement The Company’s main office is in Las Vegas, Nevada. Rent expense under all leases for the years ended June 30, 2021 and 2020 was $5,238 and $5,133 respectively. The Company maintains only one office. This office is in Las Vegas, NV and is a month-to-month lease. Related Party Transactions The Company’s Chief Executive Officer has made cash advances to the Company with an aggregate amount due of $ 0 0 7.00 As of June 30, 2021 and June 30, 2020, the Company has accrued the amounts of $ 737,642 759,948 As a result of these shareholder loans and deferred officer salary, the Company has accrued a balance of $201,846 and $ 149,481 On September 11, 2017, we received a license to certain patents from Chaya Hendrick, our founder and CEO, related to our technologies until the expiration of the patents. As consideration, we issued Chaya Hendrick, or her assigns, (i) 200,000 shares of Series B Convertible Preferred Stock, (ii) a royalty equal to 5% of gross revenues derived from products sold related to the patents, and (iii) certain minimum required payments beginning at $50,000 and doubling each year thereafter. The Series B Preferred Shares may be converted at the election of holder on a basis for 50 common shares for each preferred share at any time or an aggregate of 10,000,000 common shares in exchange for all 200,000 preferred shares. Our CEO maintains an employment agreement that stipulates a $ 190,000

DEBT

DEBT	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2021
Debt Disclosure [Abstract]
DEBT	NOTE 5 - DEBT On April 17, 2020, we received funds under the Paycheck Protection Program (the “PPP”), a part of the CARES Act. The loan is serviced by Chase Bank, and the application for these funds required us to, in good faith, certify that the current economic uncertainty made the loan necessary to support our ongoing operations. We used the funds for payroll and related costs. The receipt of these funds, and the forgiveness of the loan attendant to these funds, was dependent on our ability to adhere to the forgiveness criteria. The loan bears interest at a rate of 0.98% per annum and had a maturity date of April 6, 2022, with the first payment being deferred until April 17, 2021. Under the terms of the PPP, certain amounts may be forgiven if they are used in accordance with the CARES Act. The Company applied for forgiveness of this loan as of October 2021 and forgiveness was granted by the Small Business Administration. Therefore, the loan is considered paid in full. On March 5, 2020, the Company issued a $ 35,000 10 0.0175 5,000 On July 23, 2021, the Company entered into a securities purchase agreement with AJB Capital Investments, LLC (“AJB”) with respect to the sale and issuance of: (i) a commitment fee in the amount of $ 250,000 12,500,000 300,000 10,000,000 5,000 250,000 300,000 270,000 0.05 253,000 270,000 On January 27, 2022, the Company entered into a securities purchase agreement with Talos Victory Fund, LLC (“TVF”). The Company issued TVF a 10 250,000 12,500,000 0.001 12,500,000 On January 27, 2022, the Company entered into a securities purchase agreement with Firstfire Global Opportunities Fund (“Firstfire”). The Company issued Firstfire a 10 250,000 12,500,000 0.001 12,500,000 On January 27, 2022, the Company entered into a securities purchase agreement with Mast Hill Fund, LP (“Mast Hill”). The Company issued Mast Hill a 10 250,000 12,500,000 0.001 12,500,000 On March 8, 2022, the Company entered into a securities purchase agreement with Mast Hill Fund, LP (“Mast Hill”), in which Mast Hill shall purchase up to five million dollars ($5,000,000) of the Company’s common stock. In connection with the execution of the Agreement, on March 8, 2022, the Company issued Mast Hill five (5) common stock purchase warrants, respectively, for the purchase of (i) 500,000 shares of common stock (the “First Warrant”), (ii) 1,000,000 shares of common stock (the “Second Warrant”), (iii) 1,000,000 shares of common stock (the “Third Warrant”), (iv) 2,500,000 shares of common stock (the “Fourth Warrant”), and (v) 62,500,000 shares of the Company’s common stock (the “Fifth Warrant”) at the Exercise Price (as such term is defined in each of the Warrants) per share then in effect. On March 15, 2022, the Company entered into a securities purchase agreement with Mast Hill Fund, L.P. (“Mast Hill”). The Company issued Mast Hill: (i) a promissory note in the aggregate principal amount of $250,000 (the “Note”), (ii) a common stock purchase warrant (the “Warrant”) to purchase up to an aggregate of 12,500,000 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and (iii) 12,500,000 shares of Common Stock (the “Commitment Shares”).	NOTE 5 - DEBT In March of 2020, the Company applied for the SBA PPP government loan and was approved. On April 17,2020, the Company received $ 20,832 In March of 2021, the Company applied for the SBA PPP government loan and was approved. On March 29, 2021, the Company received $ 20,832 On March 5, 2020, the Company issued a $ 35,000 10 December 5, 2020 0.0175 5,000 2,127 2,873 35,000 The 10% convertible note is currently in default. Upon default, the fixed conversion price became a Variable Conversion Price, which is 70% multiplied by the lowest trading price for the Company’s common stock during the 20 trading day period ending on the latest complete trading day prior to the conversion date. The Company analyzed the conversion option for derivative accounting consideration under ASC 815, “ Derivatives and Hedging,” Schedule of Derivative Liabilities Level 1 Level 2 Level 3 Total Derivative liability $ - $ - $ 45,524 $ 45,524

STOCKHOLDERS_ DEFICIT

STOCKHOLDERS’ DEFICIT	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2021
Equity [Abstract]
STOCKHOLDERS’ DEFICIT	NOTE 6 STOCKHOLDERS’ DEFICIT Preferred Stock Series B Convertible Preferred Stock On December 11, 2009, the Company filed a Certificate of Designation with the State of Nevada, to designate 500,000 5,000,000 The Company issued 200,000 In October 2015, the Company issued 200,000 On September 11, 2017, the Company issued an additional 210,000 As of March 31, 2022, the Company has 5,000,000 0.001 610,000 Holders of the Series B Convertible Preferred Stock are entitled to receive dividends or other distributions with the holders of the common stock of the Company on an as converted basis when, as, and if declared by the directors of the Company. Holders of the Series B Convertible Preferred Stock are entitled to convert each share of the Series B Convertible Preferred Stock into fifty (50) shares of common stock. Upon any liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary, holders of the Series B Convertible Preferred Stock are entitled to receive out of the assets, whether capital or surplus, of the Company an amount equal to the Stated Value, pro rata with the holders of the common stock. Series C Convertible Preferred Stock From time to time, the Company issues Series C Convertible Preferred Stock in exchange for cash. These shares are convertible into shares of the Company’s common stock. The number of issued and outstanding shares of Series C Convertible Preferred Stock were 103,584 196,083 Series D Convertible Preferred Stock On July 27, 2021 the Company designated Series D Convertible Preferred Stock (the “Series D Shares”). The Series D Shares have a stated value of $100.00 (the “Stated Value”), and carry a conversion price of the volume weighted average price (for the 20 trading days immediate prior to the conversion date). The amount of shares of common stock to be issued upon any conversion shall be calculated as the quotient of (i) the product of the issued shares of the Series D Shares to be converted and the Stated Value, and (ii) the Conversion Price. The Series D Shares are not entitled to receive dividends or other distributions, and have no voting rights. Common Stock During the last fiscal quarter of fiscal year ending June 30, 2021, the Company increased its authorized shares of common stock from 600,000,000 to 1,200,000,000 As of September 30, 2021, the Company had 488,648,586 ● During the three months ended September 30, 2021, the Company sold 5,500,000 27,462 (i) 5,500,000 shares of common stock at a price of $0.10 per share and (ii) 5,500,000 shares of common stock at a price of $0.20 per share. The warrants expire at various times through September 21, 2022. None of the 12,000,000 shares of common stock were issued during the quarter ended September 30, 2021, and were recognized as stock payable. ● During the three months ended September 30, 2021, the Company issued 42,262,958 8,133,333 17,534,387 116,050 4,095,238 12,500,000 As of December 31, 2021, the Company had 539,310,756 ● During the three months ended December 31, 2021, the Company sold 8,625,000 86,230 (i) 8,625,000 shares of common stock at a price of $0.70 per share and (ii) 4,312,500 shares of common stock at a price of $1.00 per share. The warrants expire at various times through December 14, 2022. None of the 8,625,000 shares of common stock were issued during the quarter ended December 31, 2021, and were recognized as stock payable. ● During the three months ended December 31, 2021, the Company issued 50,662,170 11,032,663 19,148,052 107,000 7,981,445 12,500,000 ● During the three months ended March 31, 2022, the Company issued 77,040,836 15,826,550 90,750 3,714,286 57,500,000 783,000 During the three months ended March 31, 2022, the Company sold 2,000,000 19,980 (i) 2,000,000 shares of common stock at a price of $0.70 per share and (ii) 1,000,000 shares of common stock at a price of $1.00 per share. The warrants expire at various times through February 9, 2023. None of the 2,000,000 shares of common stock were issued during the quarter ended March 31, 2022, and were recognized as stock payable. Equity Financing Agreement On March 5, 2020, the Company entered into an equity financing agreement (the “Equity Financing Agreement”) with GHS Investments, LLC, a Nevada limited liability company (“GHS”). Pursuant to the Equity Financing Agreement, the Company agreed to sell to GHS an indeterminate amount of shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), up to an aggregate price of four million dollars ($4,000,000). Following effectiveness of the Registration Statement, the Company shall have the discretion to deliver puts to GHS and GHS will be obligated to purchase shares of the Company’s Common Stock based on the investment amount specified in each put notice. The maximum amount that the Company shall be entitled to put to GHS in each put notice shall not exceed two hundred percent (200%) of the average daily trading dollar volume of the Company’s Common Stock during the ten (10) trading days preceding the put, so long as such dollar amount does not exceed $500,000. Pursuant to the Equity Financing Agreement, GHS and its affiliates will not be permitted to purchase and the Company may not put shares of the Company’s Common Stock to GHS that would result in GHS’s beneficial ownership, equaling more than 4.99% of the Company’s outstanding Common Stock. The price of each put share shall be equal to eighty percent (80%) of the Market Price (as defined in the Equity Financing Agreement). Puts may be delivered by the Company to GHS until the earlier of thirty-six (36) months after the effectiveness of the Registration Statement. Concurrently with the execution of the Equity Financing Agreement, the Company entered into a convertible promissory note, for the principal balance of $ 35,000 10 0.0175 35,000 Warrants From time to time the Company granted warrants in connection with private placements of securities, as described herein. As of March 31, 2022, and June 30, 2021, the following is a breakdown of the warrant activity: Schedule of share based compensation warrant activity Range of Exercise Prices Number of Weighted- Weighted- Number Weighted- Warrants Outstanding and Exercisable at March 31, 2022: $0.70 - $1.00 54,664,518 1.20 $ 0.26 54,664,518 $ 0.26 Warrants Outstanding and Exercisable at June 30, 2021: $0.10 - $0.20 124,888,519 1.12 $ 0.33 124,888,519 $ 0.33 Warrant Activity: March 31, 2022: Schedule of warrant activity Outstanding - June 30, 2021 124,888,519 Issued 22,937,499 Exercised — Expired (93,161,500 ) Outstanding - March 31, 2022 54,664,518 March 31, 2021: Outstanding - June 30, 2020 53,280,406 Issued 90,500,000 Exercised — Expired (17,151,887 ) Outstanding - March 31, 2021 126,628,519 At March 31, 2022, all 54,664,518 54,664,518	NOTE 6 - STOCKHOLDERS’ DEFICIT Preferred Stock As of June 30, 2021, the Company has 5,000,000 0.001 610,000 Each share of Series B Convertible Preferred Stock has a par value of $0.001, and a stated value equal to $ 5.00 Upon any liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary (“liquidation”), holders of the Series B Convertible Preferred Stock are entitled to receive out of the assets, whether capital or surplus, of the Company an amount equal to the Stated Value, pro rata with the holders of the common stock. The Company issued 200,000 In October 2015, the Company issued 200,000 On September 11, 2017, the Company issued an additional 210,000 Class A Common Stock As of June 30, 2021, the Company has 50,000,000 0.001 no During the three month period ending December 31, 2019, the Company increased its total number of shares of authorized capital stock to 600,000,000 0.001 Common Stock and Warrants ● During the three months ended September 30, 2019, the Company sold for cash 6,337,500 6,337,500 0.10 0.25 133,495 September 17, 2021 6,337,500 ● During the three months ended December 31, 2019, the Company sold for cash 40,675,000 825,000 0.20 0.25 214,510 November 1, 2021 40,675,000 36,300 2,370,696 ● During the three months ended March 31, 2020, the Company sold for cash 9,550,000 3,500,000 0.05 1.00 66,500 March 12, 2022 9,550,000 ● During the three months ended June 30, 2020, the Company sold for cash 40,000,000 12,000,000 0.10 0.20 200,905 June 12, 2021 9,000,000 ● During the three months ended September 30, 2020, the Company sold for cash 17,500,000 (i) 17,500,000 shares at prices ranging from $0.05 per share to $0.10 per share and (ii) 14,500,000 shares at prices ranging from $0.10 to $0.20 for net proceeds of $77,409. The warrants expire at various times through September 21, 2022. 17,500,000 17,500,000 6,032,260 585,000 5,447,260 ● During the three months ended December 31, 2020, the Company sold 16,500,000 82,455 (i) 16,500,000 shares at prices ranging from $0.05 to $0.10 per share and (ii) 16,500,000 December 21, 2022 16,500,000 ● During the three months ended December 31, 2020, the Company issued 32,034,876 75,000 15,000,000 16,034,876 78,100 ● During the three months ended March 31, 2021, the Company sold 11,000,000 59,957 (i) 12,000,000 shares at a price of $0.10 per share and (ii) 12,000,000 shares at a price of $0.20. February 4, 2022 12,000,000 ● During the three months ended March 31, 2021, the Company issued 26,769,540 17,000,000 6,709,100 72,600 2,560,440 ● During the three months ended June 30, 2021, the Company sold 3,333,333 (i) 3,333,333 June 8, 2022 3,333,333 ● During the three months ended June 30, 2021, the Company issued 3,025,952 36,300 The following information summarizes the warrants outstanding and exercisable. Warrants Outstanding and Exercisable at June 30, 2021: Schedule of share based compensation warrant activity Range of Exercise Prices Number of Warrants Outstanding Weighted- Average Contractual Life Remining in Years Weighted- Average Exercise Price Number Exercisable Weighted- Average Exercise Price Warrants Outstanding and Exercisable at June 30, 2020: $ 0.05 1.00 53,280,406 1.120 $ 0.33 53,280,406 $ 0.33 Warrants Outstanding and Exercisable at June 30, 2021: $ 0.10 0.20 124,888,519 0.623 $ 0.18 124,888,519 $ 0.623 Warrant Activity: As of June 30, 2021 and 2020, the following is a breakdown of the activity: June 30, 2021: Schedule of warrant activity Outstanding - beginning of year 53,280,406 Issued 98,500,000 Exercised — Expired (26,891,887 ) Outstanding - end of year 124,888,519 June 30, 2020: Outstanding - beginning of year 26,526,234 Issued 34,662,500 Exercised — Expired (7,908,328 ) Outstanding - end of year 53,280,406 At June 30, 2021, all of the 124,888,519 124,888,519 Equity Financing On March 5, 2020, the Company entered into an equity financing agreement with GHS Investments, LLC, a Nevada limited liability company (“Investor”). Pursuant to the agreement, the Company agrees the sell to the investor an indeterminate amount of shares of the Company’s common stock, par value $0.001 per share, up to an aggregate price of four million dollars ($4,000,000). Pursuant to the agreement, the Company is required, to within sixty (60) calendar days upon the date of execution of this agreement, use its best efforts to file with the SEC a registration statement or registration statements (as is necessary) on Form S-1, covering the resale of all of the registrable securities, which registration statement(s) shall state that, in accordance with Rule 416 promulgated under the 1933 Act, such registration statement also covers such indeterminate number of additional shares of Common Stock as may become issuable upon stock splits, stock dividends or similar transactions. Pursuant to this equity financing agreement, the Company filed the Registration S-1 on August 6, 2020. Following effectiveness of the Registration Statement, the Company shall have the discretion to deliver puts to GHS and GHS will be obligated to purchase shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”) based on the investment amount specified in each put notice. The maximum amount that the Company shall be entitled to put to GHS in each put notice shall not exceed two hundred percent (200%) of the average daily trading dollar volume of the Company’s Common Stock during the ten (10) trading days preceding the put, so long as such dollar amount does not exceed $500,000. Pursuant to the Equity Financing Agreement, GHS and its affiliates will not be permitted to purchase and the Company may not put shares of the Company’s Common Stock to GHS that would result in GHS’s beneficial ownership, equaling more than 4.99% of the Company’s outstanding Common Stock. The price of each put share shall be equal to eighty percent (80%) of the Market Price (as defined in the Equity Financing Agreement). Puts may be delivered by the Company to GHS until the earlier of thirty-six (36) months after the effectiveness of the Registration Statement. Concurrently with the execution of the equity financing agreement, the company entered into a convertible promissory note, for the principal balance of $ 35,000 10 0.0175 35,000

MANDATORY REDEEMABLE CONVERTIBL

MANDATORY REDEEMABLE CONVERTIBLE PREFERRED STOCK	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2021
Mandatory Redeemable Convertible Preferred Stock
MANDATORY REDEEMABLE CONVERTIBLE PREFERRED STOCK	NOTE 7 MANDATORY REDEEMABLE CONVERTIBLE PREFERRED STOCK Issuances of Series C Convertible Preferred Stock On January 10, 2019, the Board of Directors of the Company adopted a resolution pursuant to the Company’s Certificate of Incorporation, as amended, providing for the designations, preferences and relative, participating, optional and other rights, and the qualifications, limitations and restrictions, of the Series C Convertible Preferred Stock. On January 14, 2019, the Company filed a Certificate of Designations for its Series C Convertible Preferred Stock. The authorized number of Series C Convertible Preferred Stock is 1,000,000 0.001 10 105 130 The number of shares of Series C Convertible Preferred Stock issued and outstanding were 103,584 196,084 The holders of Series C Convertible Preferred Stock shall have the right at any time during the period beginning on the date which is six (6) months following the date of their issuance, to convert all or any part of the outstanding Series C Convertible Preferred Stock into fully paid and non-assessable shares of common stock at the Variable Conversion Price. The “Variable Conversion Price” shall mean 71% multiplied by the Market Price (representing a discount rate of 29%). “Market Price” means the average of the two (2) lowest Trading Prices (which means, for any security as of any date, the closing bid price on the OTCQB, OTCQX, Pink Sheets electronic quotation system or applicable trading market (the “OTC”) as reported by a reliable reporting service (“Reporting Service”) designated by the holder (i.e. Bloomberg) for the common stock during the fifteen (15) Trading Day Period ending on the latest complete Trading Day prior to the date of conversion (both terms as defined in the Certificate of Designations) The Series C Convertible Preferred stock is convertible after six months at 71 35,000 On the date which is eighteen (18) months following the Issuance Date or upon the occurrence of an Event of Default (the “Mandatory Redemption Date”), the Company shall redeem all of the shares of Series C Convertible Preferred Stock of the holder (which have not been previously redeemed or converted). Within five (5) days of the Mandatory Redemption Date, the Company shall make payment to each holder of an amount in cash equal to the total number of shares of Series C Convertible Preferred Stock held by such holder multiplied by the then current Stated Value. All shares of mandatorily redeemable convertible preferred stock have been presented outside of permanent equity in accordance with ASC 480, Classification and Measurement of Redeemable Securities i.e. The carrying value of the Series C Convertible Preferred Stock at March 31, 2022 and June 30, 2021 was $ 103,584 196,083 There were 48,125 shares of Series C Preferred Stock issued for net proceeds of $40,000, and 90,750 shares of Series C Preferred Stock converted to 15,826,550 shares of common stock for the three months ended March 31, 2022.	NOTE 7 MANDATORY REDEEMABLE CONVERTIBLE PREFERRED STOCK Issuances of Series C Mandatory Redeemable Convertible Preferred Stock On January 10, 2019, the Board of Directors of the Company adopted a resolution pursuant to the Company’s Certificate of Incorporation, as amended, providing for the designations, preferences and relative, participating, optional and other rights, and the qualifications, limitations and restrictions, of the Series C Convertible Preferred Stock. On January 14, 2019, the Company filed a Certificate of Designations for a Series C Convertible Preferred Stock. The authorized number of Series C Convertible Preferred Stock is 1,000,000 0.001 10 105 130 The number of Series C, mandatory redeemable convertible preferred stock shares issued and outstanding were 239,025 117,200 The Holder shall have the right at any time during the period beginning on the date which is six (6) months following the Issuance Date, to convert all or any part of the outstanding Series C Preferred Stock into fully paid and non-assessable shares of Common Stock at the Variable Conversion Price. The “Variable Conversion Price” shall mean 71 On the date which is eighteen (18) months following the Issuance Date or upon the occurrence of an Event of Default (the “Mandatory Redemption Date”), the Company shall redeem all of the shares of Series C Preferred Stock of the Holder (which have not been previously redeemed or converted). With five (5) days of the Mandatory Redemption Date, the Company shall make payment to each Holder of an amount in cash equal to the total number of shares of Series C Preferred Stock held by such Holder multiplied by the then current Stated Value. All shares of mandatorily redeemable convertible preferred stock have been presented outside of permanent equity in accordance with ASC 480, Classification and Measurement of Redeemable Securities The carrying value of the Series C mandatory redeemable convertible preferred stock at June 30, 2021 and 2020 was $ 196,083 101,661 The estimated fair value of the Series C, mandatory redeemable convertible preferred stock at June 30, 2021 and 2020 was $ 196,083 101,661 The Company recorded preferred stock dividends of $ 163,575 32,024 2,442 2,945

INCOME TAXES

INCOME TAXES	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2021
Income Tax Disclosure [Abstract]
INCOME TAXES	NOTE 9 INCOME TAXES The Company provides for income taxes at the end of each interim period based on the estimated effective tax rate for the full fiscal year. Cumulative adjustments to the Company’s estimate are recorded in the interim period in which a change in the estimated annual effective rate is determined. The Company has estimated its effective tax rate to be 0	NOTE 8 - INCOME TAXES Deferred income taxes are determined using the liability method for the temporary differences between the financial reporting basis and income tax basis of the Company’s assets and liabilities. Deferred income taxes are measured based on the tax rates expected to be in effect when the temporary differences are included in the Company’s tax return. Deferred tax assets and liabilities are recognized based on anticipated future tax consequences attributable to differences between financial statement carrying amounts of assets and liabilities and their respective tax bases. The Company recognizes interest and penalties related to income tax matters as a component of income tax expense. At June 30, 2021 and 2020, deferred tax assets consist of the following: Schedule of deferred tax assets and liabilities 2021 2020 Net operating loss carryforward $ 9,789,107 $ 8,983,161 Warrant issuances — — Deferred officer compensation 737,642 805,848 Other - 0 98 Valuation allowance (10,526,749 ) (9,789,107 ) $ — $ — At June 30, 2021, the Company had a net operating loss carry-forwards in the amount of approximately $ 28.9 80 Schedule of effective income tax rate reconciliation 2021 2020 Tax on income before income tax 21.00 % 21.00 % Effect of non-temporary differences (0.01 )% (0.01 )% Effect of prior year items — % — % Effect of temporary differences — % — % Change in valuation allowance (20.99 )% (20.99 )% Effective Income Tax Rate Reconciliation, Percent 0.00 % 0.00 % The total amount of unrecognized tax benefits can change due to tax examination activities, lapse of applicable statutes of limitations and the recognition and measurement criteria under the guidance related to accounting for uncertainty in income taxes. The Company does not believe any significant increases or decreases will occur within the next twelve months. The Company files income tax returns in the United States (“U.S.”) federal jurisdiction. Generally, the Company is no longer subject to U.S. federal examinations by tax authorities for fiscal years prior to 2017. The Company does not file in any other jurisdiction and remains open for audit for all tax years as the statute of limitations does not begin until the returns are filed. The Company remains subject to U.S. federal examination for tax years ended 2017, 2018, 2019, 2020 and 2021.

LITIGATION

LITIGATION	12 Months Ended
	Jun. 30, 2021
Litigation
LITIGATION	NOTE 9 - LITIGATION From time to time we may be a defendant or plaintiff in various legal proceedings arising in the normal course of our business. We know of no material, active, pending or threatened proceeding against us or our subsidiaries, nor are we, or any subsidiary, involved as a plaintiff or defendant in any material proceeding or pending litigation.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2021
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 10 SUBSEQUENT EVENTS In accordance with ASC 855-10, the Company has reviewed its operations subsequent to March 31, 2022 to the date these financial statements were issued. Between April 1, 2022 an d May 18, 2022, ot her than as described in “Recent Developments” in Part I, Item 2 of this Quarterly Report, there were no subsequent events.	NOTE 10 - SUBSEQUENT EVENTS In accordance with ASC 855-10, the Company has reviewed its operations subsequent to June 30, 2021 to the date these financial statements were issued. Subsequent to June 30, 2021, the Company issued 48,125 43,745 26,473,580 51,850 5,940,247

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 4 - COMMITMENTS AND CONTINGENCIES Lease Agreement The Company’s main office is in Las Vegas, Nevada. Rent expense under all leases for the three months ended March 31, 2022 and 2021 was $ 1,537 1,590 Related Party Transactions As of March 31, 2022 and 2021, the Company has accrued the amounts of $ 753,475 744,115 As a result of shareholder loans and deferred officer salary, the Company has accrued a balance of $ 240,712 188,686 On September 11, 2017, we received a license to certain patents from Chaya Hendrick, our founder and CEO, related to our technologies until the expiration of the patents. As consideration, we issued Chaya Hendrick, or her assigns, (i) 200,000 shares of Series B Convertible Preferred Stock, (ii) a royalty equal to 5% of gross revenues derived from products sold related to the patents, and (iii) certain minimum required payments beginning at $50,000 and doubling each year thereafter. The Series B Preferred Stock may be converted at the election of holder on a basis for 50 common shares for each preferred share at any time or an aggregate of 10,000,000 common shares in exchange for all 200,000 shares of Series B Convertible Preferred Stock. Our CEO maintains an employment agreement that stipulates a $ 190,000 Litigation From time to time we may be a defendant or plaintiff in various legal proceedings arising in the normal course of our business. As of the date of this Quarterly Report, there are no material pending legal or governmental proceedings relating to us or properties to which we are a party, and, to our knowledge, there are no material proceedings to which any of our directors, executive officers or affiliates are a party adverse to us or which have a material interest adverse to us.	NOTE 4 - COMMITMENTS Lease Agreement The Company’s main office is in Las Vegas, Nevada. Rent expense under all leases for the years ended June 30, 2021 and 2020 was $5,238 and $5,133 respectively. The Company maintains only one office. This office is in Las Vegas, NV and is a month-to-month lease. Related Party Transactions The Company’s Chief Executive Officer has made cash advances to the Company with an aggregate amount due of $ 0 0 7.00 As of June 30, 2021 and June 30, 2020, the Company has accrued the amounts of $ 737,642 759,948 As a result of these shareholder loans and deferred officer salary, the Company has accrued a balance of $201,846 and $ 149,481 On September 11, 2017, we received a license to certain patents from Chaya Hendrick, our founder and CEO, related to our technologies until the expiration of the patents. As consideration, we issued Chaya Hendrick, or her assigns, (i) 200,000 shares of Series B Convertible Preferred Stock, (ii) a royalty equal to 5% of gross revenues derived from products sold related to the patents, and (iii) certain minimum required payments beginning at $50,000 and doubling each year thereafter. The Series B Preferred Shares may be converted at the election of holder on a basis for 50 common shares for each preferred share at any time or an aggregate of 10,000,000 common shares in exchange for all 200,000 preferred shares. Our CEO maintains an employment agreement that stipulates a $ 190,000

DERIVATIVE LIABILITIES

DERIVATIVE LIABILITIES	9 Months Ended
	Mar. 31, 2022
Derivative Liabilities
DERIVATIVE LIABILITIES	NOTE 8 DERIVATIVE LIABILITIES The conversion rates of the convertible notes and Series C Convertible Preferred Stock are convertible at a variable rate. Accordingly, the Company concluded there is an embedded derivative which was required to be bifurcated and accounted for as a derivative liability. The Company chose to use the Black Scholes model to calculate the derivative liability. The assumptions in the derivative liability calculation included the price of the Company’s common stock of $ 0.0141 0.0010 0.0011 150 341 Schedule of derivative liability Level 1 Level 2 Level 3 Total Derivative liability $ - $ - $ 155,973 $ 155,973

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2021
Accounting Policies [Abstract]
Recent Accounting Pronouncements	Recent Accounting Pronouncements The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position or cash flow.	Recent Accounting Pronouncements The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position or cash flow except as noted below. In February 2016, the FASB issued authoritative guidance ASC 842, “Leases.” This guidance requires lessees to recognize most leases on the balance sheet by recording a right-of-use asset and a lease liability. The Company has made the decision to adopt this guidance early, and it was adopted by the Company as of March 1, 2019. Based on the completed analysis, the Company has determined that the adjustment did not have a material impact on the financial statements. In June 2018, the FASB issued ASU 2018-07, Compensation—Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting, which aligns accounting for share-based payments issued to nonemployees to that of employees under the existing guidance of Topic 718, with certain exceptions. This update supersedes previous guidance for equity-based payments to nonemployees under Subtopic 505-50, Equity—Equity-Based Payments to Non-Employees. This guidance was adopted by the Company as of March 1, 2019. Based on the completed analysis, the Company has determined the adjustment did not have a material impact on the financial statements.
Principles of Consolidation		Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, SmartMetric Australia Pty. Ltd. All significant intercompany accounts and transactions have been eliminated in consolidation.
Fair value of financial instruments	Fair value of financial instruments The Company measures fair value in accordance with ASC 820 - Fair Value Measurements. ASC 820 defines fair value and establishes a three-level valuation hierarchy for disclosures of fair value measurements. ASC 820 establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, ASC 820 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three (3) levels of fair value hierarchy defined by ASC 820 are: Level 1 Level 2 Level 3 As defined by ASC 820, the fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced or liquidation sale, which was further clarified as the price that would be received to sell an asset or paid to transfer a liability (“an exit price”) in an orderly transaction between market participants at the measurement date. The reported fair values for financial instruments that use Level 2 and Level 3 inputs to determine fair value are based on a variety of factors and assumptions. Accordingly, certain fair values may not represent actual values of the Company’s financial instruments that could have been realized as of March 31, 2022 or that will be recognized in the future, and do not include expenses that could be incurred in an actual settlement. The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts receivable, receivables from related parties, prepaid expenses and other, accounts payable, accrued liabilities, and related party and third-party notes payables approximate fair value due to their relatively short maturities. The Company’s notes payable to related parties approximates the fair value of such instrument based upon management’s best estimate of terms that would be available to the Company for similar financial arrangements at March 31, 2022.	Fair Value of Financial Instruments The carrying amounts reflected in the balance sheets for cash, accounts payable and related party payables approximate the respective fair values due to the short maturities of these items. As required by the Fair Value Measurements and Disclosures Topic of the FASB ASC, fair value is measured based on a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: (Level 1) observable inputs such as quoted prices in active markets; (Level 2) inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and (Level 3) unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. The three levels of the fair value hierarchy are described below: Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities; Level 2: Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability; Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity). The Company at present does not have any Level 2 or Level 3 fair value instruments.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, the Company evaluates its estimates, including, but not limited to, those related to income taxes and contingencies. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates.	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, the Company evaluates its estimates, including, but not limited to, those related to income taxes and contingencies. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates.
Cash		Cash The Company considers all highly liquid debt instruments and other short-term investments with an initial maturity of three months or less to be cash equivalents. Any amounts of cash in financial institutions which exceed FDIC insured limits exposes the Company to cash concentration risk. The Company had no
Research and Development	Research and Development Research and development costs are charged to expense as incurred. Our research and development expenses consist primarily of expenditures for electronics design and engineering, software design and engineering, component sourcing, component engineering, manufacturing, product trials, compensation and consulting costs.	Research and Development Research and development costs are charged to expense as incurred. Our research and development expenses consist primarily of expenditures for electronics design and engineering, software design and engineering, component sourcing, component engineering, manufacturing, product trials, compensation and consulting costs.
Revenue Recognition		Revenue Recognition The Company has not recognized revenues to date. Therefore, the Company has not yet adopted a revenue recognition policy.
Reclassifications		Reclassifications Certain prior year amounts have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the reported results of operations.
Uncertainty in Income Taxes		Uncertainty in Income Taxes GAAP requires the recognition and measurement of uncertain income tax positions using a “more-likely-than-not” approach. Management evaluates Company tax positions on an annual basis and has determined that as of June 30, 2021 and 2020, no accrual for uncertain income tax positions is necessary.
Loss Per Share of Common Stock	Loss Per Share of Common Stock In accordance with FASB ASC 260, “Earnings Per Share,” the basic loss per share is computed by dividing the loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. Basic net loss per share excludes the dilutive effect of stock options or warrants and convertible notes. Diluted net earnings (loss) per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents, consisting of shares that might be issued upon exercise of common stock options and warrants. In periods where losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of March 31, 2022 and 2021, 54,664,518 126,628,519	Loss Per Share of Common Stock In accordance with FASB ASC 260, “Earnings Per Share,” the basic loss per share is computed by dividing the loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. Basic net loss per share excludes the dilutive effect of stock options or warrants and convertible notes. Diluted net earnings (loss) per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents, consisting of shares that might be issued upon exercise of common stock options and warrants. In periods where losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of June 30, 2021 and 2020, 124,888,519 53,280,406
Stock-Based Compensation	Stock-Based Compensation The Company records stock-based compensation in accordance with ASC 718, Compensation – Stock Compensation Equity-Based Payments to Non-Employees

DEBT (Tables)

DEBT (Tables)	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2021
Debt Disclosure [Abstract]
Schedule of Derivative Liabilities	Schedule of derivative liability Level 1 Level 2 Level 3 Total Derivative liability $ - $ - $ 155,973 $ 155,973	Schedule of Derivative Liabilities Level 1 Level 2 Level 3 Total Derivative liability $ - $ - $ 45,524 $ 45,524

STOCKHOLDERS_ DEFICIT (Tables)

STOCKHOLDERS’ DEFICIT (Tables)	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2021
Equity [Abstract]
Schedule of share based compensation warrant activity	Schedule of share based compensation warrant activity Range of Exercise Prices Number of Weighted- Weighted- Number Weighted- Warrants Outstanding and Exercisable at March 31, 2022: $0.70 - $1.00 54,664,518 1.20 $ 0.26 54,664,518 $ 0.26 Warrants Outstanding and Exercisable at June 30, 2021: $0.10 - $0.20 124,888,519 1.12 $ 0.33 124,888,519 $ 0.33	Schedule of share based compensation warrant activity Range of Exercise Prices Number of Warrants Outstanding Weighted- Average Contractual Life Remining in Years Weighted- Average Exercise Price Number Exercisable Weighted- Average Exercise Price Warrants Outstanding and Exercisable at June 30, 2020: $ 0.05 1.00 53,280,406 1.120 $ 0.33 53,280,406 $ 0.33 Warrants Outstanding and Exercisable at June 30, 2021: $ 0.10 0.20 124,888,519 0.623 $ 0.18 124,888,519 $ 0.623
Schedule of warrant activity	Schedule of warrant activity Outstanding - June 30, 2021 124,888,519 Issued 22,937,499 Exercised — Expired (93,161,500 ) Outstanding - March 31, 2022 54,664,518 March 31, 2021: Outstanding - June 30, 2020 53,280,406 Issued 90,500,000 Exercised — Expired (17,151,887 ) Outstanding - March 31, 2021 126,628,519	Schedule of warrant activity Outstanding - beginning of year 53,280,406 Issued 98,500,000 Exercised — Expired (26,891,887 ) Outstanding - end of year 124,888,519 June 30, 2020: Outstanding - beginning of year 26,526,234 Issued 34,662,500 Exercised — Expired (7,908,328 ) Outstanding - end of year 53,280,406

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Jun. 30, 2021
Income Tax Disclosure [Abstract]
Schedule of deferred tax assets and liabilities	Schedule of deferred tax assets and liabilities 2021 2020 Net operating loss carryforward $ 9,789,107 $ 8,983,161 Warrant issuances — — Deferred officer compensation 737,642 805,848 Other - 0 98 Valuation allowance (10,526,749 ) (9,789,107 ) $ — $ —
Schedule of effective income tax rate reconciliation	Schedule of effective income tax rate reconciliation 2021 2020 Tax on income before income tax 21.00 % 21.00 % Effect of non-temporary differences (0.01 )% (0.01 )% Effect of prior year items — % — % Effect of temporary differences — % — % Change in valuation allowance (20.99 )% (20.99 )% Effective Income Tax Rate Reconciliation, Percent 0.00 % 0.00 %

DERIVATIVE LIABILITIES (Tables)

DERIVATIVE LIABILITIES (Tables)	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2021
Derivative Liabilities
Schedule of derivative liability	Schedule of derivative liability Level 1 Level 2 Level 3 Total Derivative liability $ - $ - $ 155,973 $ 155,973	Schedule of Derivative Liabilities Level 1 Level 2 Level 3 Total Derivative liability $ - $ - $ 45,524 $ 45,524

ORGANIZATION AND BASIS OF PRE_2

ORGANIZATION AND BASIS OF PRESENTATION (Details Narrative) - USD ($)	Mar. 05, 2020	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021	Jun. 30, 2021	Jun. 30, 2020
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Recurring losses		$ (20,044)	$ 213,122	$ 1,399,499	$ 733,211	$ 924,728	$ 805,577
Accumulated deficit		$ 30,269,453		$ 30,269,453		$ 28,859,365	$ 27,771,062
GHS Investments LLC [Member]
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Investor agrees to invest amount	$ 4,000,000

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	9 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Jun. 30, 2021	Jun. 30, 2020
Accounting Policies [Abstract]
Cash equivalents			$ 0	$ 0
Dilutive shares were excluded from diluted loss per common share	54,664,518	126,628,519	124,888,519	53,280,406

PREPAID EXPENSES (Details Narra

PREPAID EXPENSES (Details Narrative) - USD ($)	Mar. 31, 2022	Jun. 30, 2021
Prepaid Expenses
Prepaid expenses	$ 20,470	$ 5,000

COMMITMENTS (Details Narrative)

COMMITMENTS (Details Narrative) - USD ($)	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2021	Jun. 30, 2020
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Accrued the amounts	$ 753,475	$ 737,642	$ 759,948
Accrued balance of interest payable	240,712	188,686	149,481
Annual salary	$ 190,000	190,000
Chief Executive Officer [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Aggregate amount due		$ 0	$ 0
Interest rate		7.00%

Debt (Details)

Debt (Details)	Jun. 30, 2021USD ($)
Defined Benefit Plan Disclosure [Line Items]
Derivative liability	$ 45,524
Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Derivative liability
Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Derivative liability
Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Derivative liability	$ 45,524

DEBT (Details Narrative)

DEBT (Details Narrative) - USD ($)

Mar. 15, 2022

Mar. 08, 2022

Mar. 05, 2020

Jan. 27, 2022

Jul. 23, 2021

Mar. 29, 2021

Apr. 17, 2020

Mar. 31, 2022

Dec. 31, 2021

Sep. 30, 2021

Jun. 30, 2021

Mar. 31, 2021

Dec. 31, 2020

Sep. 30, 2020

Mar. 31, 2022

Mar. 31, 2021

Jun. 30, 2021

Jun. 30, 2020

Debt Instrument [Line Items]

Proceeds from loan

$ 20,832

$ 20,832

$ 20,832

Convertible note

$ 35,000

Convertible note, percentage

10.00%

Maturity date

Dec. 5, 2020

Beneficial conversion feature

$ 5,000

5,000

Amortization of debt discount

$ 30,000

$ 2,873

2,873

$ 2,127

Unamortized discount

$ 35,000

$ 35,000

Common stock, par value

$ 0.001

$ 0.001

$ 0.001

$ 0.001

$ 0.001

Warrants to purchase shares, description

(i) a promissory note in the aggregate principal amount of $250,000 (the “Note”), (ii) a common stock purchase warrant (the “Warrant”) to purchase up to an aggregate of 12,500,000 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and (iii) 12,500,000 shares of Common Stock (the “Commitment Shares”).

(5) common stock purchase warrants, respectively, for the purchase of (i) 500,000 shares of common stock (the “First Warrant”), (ii) 1,000,000 shares of common stock (the “Second Warrant”), (iii) 1,000,000 shares of common stock (the “Third Warrant”), (iv) 2,500,000 shares of common stock (the “Fourth Warrant”), and (v) 62,500,000 shares of the Company’s common stock (the “Fifth Warrant”) at the Exercise Price (as such term is defined in each of the Warrants) per share then in effect.

(i) 2,000,000 shares of common stock at a price of $0.70 per share and (ii) 1,000,000 shares of common stock at a price of $1.00 per share. The warrants expire at various times through February 9, 2023. None of the 2,000,000 shares of common stock were issued during the quarter ended March 31, 2022, and were recognized as stock payable.

(i) 8,625,000 shares of common stock at a price of $0.70 per share and (ii) 4,312,500 shares of common stock at a price of $1.00 per share. The warrants expire at various times through December 14, 2022. None of the 8,625,000 shares of common stock were issued during the quarter ended December 31, 2021, and were recognized as stock payable.

(i) 5,500,000 shares of common stock at a price of $0.10 per share and (ii) 5,500,000 shares of common stock at a price of $0.20 per share. The warrants expire at various times through September 21, 2022. None of the 12,000,000 shares of common stock were issued during the quarter ended September 30, 2021, and were recognized as stock payable.

(i) 3,333,333 shares at a price of $0.10 per share and (ii) 3,333,333 shares at a price of $0.20.

(i) 12,000,000 shares at a price of $0.10 per share and (ii) 12,000,000 shares at a price of $0.20.

(i) 16,500,000 shares at prices ranging from $0.05 to $0.10 per share and (ii) 16,500,000 shares at prices ranging from $0.10 to $0.20 and (iii) 1,500,000 at a price of $0.30.

(i) 17,500,000 shares at prices ranging from $0.05 per share to $0.10 per share and (ii) 14,500,000 shares at prices ranging from $0.10 to $0.20 for net proceeds of $77,409. The warrants expire at various times through September 21, 2022.

Securities Purchase Agreement [Member] | A J B Capital Investments [Member]

Debt Instrument [Line Items]

Stock issued for commitment fee, amount

$ 250,000

Stock issued for commitment fee, Shares

12,500,000

Principal amount

$ 300,000

Number of warrant purchase

10,000,000

Original issue discount

$ 300,000

Purchase Price

$ 270,000

Exercise Price

$ 0.05

Notes and warrants due

$ 253,000

Interest rate

10.00%

Securities Purchase Agreement [Member] | A J B Capital Investments [Member] | Series D Preferred Stock [Member]

Debt Instrument [Line Items]

Shares issued

5,000

Securities Purchase Agreement [Member] | Talos Victory Fund L L C [Member]

Debt Instrument [Line Items]

Principal amount

$ 250,000

Securities Purchase Agreement [Member] | Talos Victory Fund L L C [Member] | Common Stock [Member]

Debt Instrument [Line Items]

Number of warrant purchase

12,500,000

Common stock, par value

$ 0.001

Securities Purchase Agreement [Member] | Talos Victory Fund L L C [Member] | Warrant [Member]

Debt Instrument [Line Items]

Number of warrant purchase

12,500,000

Securities Purchase Agreement [Member] | Firstfire Global Opportunities Fund [Member]

Debt Instrument [Line Items]

Principal amount

$ 250,000

Interest rate

10.00%

Securities Purchase Agreement [Member] | Firstfire Global Opportunities Fund [Member] | Common Stock [Member]

Debt Instrument [Line Items]

Number of warrant purchase

12,500,000

Common stock, par value

$ 0.001

Securities Purchase Agreement [Member] | Firstfire Global Opportunities Fund [Member] | Warrant [Member]

Debt Instrument [Line Items]

Number of warrant purchase

12,500,000

Securities Purchase Agreement [Member] | Mast Hill Fund L P [Member]

Debt Instrument [Line Items]

Principal amount

$ 250,000

Interest rate

10.00%

Securities Purchase Agreement [Member] | Mast Hill Fund L P [Member] | Common Stock [Member]

Debt Instrument [Line Items]

Number of warrant purchase

12,500,000

Common stock, par value

$ 0.001

Securities Purchase Agreement [Member] | Mast Hill Fund L P [Member] | Warrant [Member]

Debt Instrument [Line Items]

Number of warrant purchase

12,500,000

PPP Loan [Member]

Debt Instrument [Line Items]

Proceeds from loan

$ 20,832

$ 20,832

Convertible Promissory Note [Member]

Debt Instrument [Line Items]

Conversion price per share (in Dollars per share)

$ 0.0175

Principal amount

$ 35,000,000

Stockholderss' Deficit (Details

Stockholderss' Deficit (Details) - $ / shares	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2021	Jun. 30, 2020
Equity [Abstract]
Exercise Price Range, Lower Range Limit		$ 0.10	$ 0.05
Exercise Price Range, Upper Range Limit		$ 0.20	$ 1
Number of Warrants Outstanding (in Shares)	54,664,518	124,888,519	53,280,406
Weighted-Average Contractual Life Remaining in Years	1 year 2 months 12 days	1 year 1 month 13 days	1 year 1 month 13 days
Weighted- Average Exercise Price	$ 0.26	$ 0.33	$ 0.33
Number Exercisable (in Shares)	54,664,518	124,888,519	53,280,406
Weighted- Average Exercise Price	$ 0.26	$ 0.33	$ 0.33

Stockholdrs' Deficit (Details 1

Stockholdrs' Deficit (Details 1) - shares	9 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Jun. 30, 2021	Jun. 30, 2020
Equity [Abstract]
Outstanding - beginning of year	124,888,519	53,280,406	53,280,406	26,526,234
Issued	22,937,499	90,500,000	98,500,000	34,662,500
Exercised
Expired	(93,161,500)	(17,151,887)	(26,891,887)	(7,908,328)
Outstanding - end of year	54,664,518	126,628,519	124,888,519	53,280,406
Outstanding - end of year	54,664,518	126,628,519	124,888,519	53,280,406

STOCKHOLDERS_ DEFICIT (Details

STOCKHOLDERS’ DEFICIT (Details Narrative) - USD ($)	Mar. 15, 2022	Mar. 08, 2022	Mar. 05, 2020	Sep. 11, 2017	Oct. 31, 2015	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Mar. 31, 2022	Mar. 31, 2021	Jun. 30, 2021	Jun. 30, 2020	Jan. 14, 2019	Nov. 05, 2014	Dec. 11, 2009
Class of Stock [Line Items]
Preferred stock, shares authorized						5,000,000			5,000,000				5,000,000				5,000,000		5,000,000	5,000,000
Preferred stock, par value (in Dollars per share)						$ 0.001			$ 0.001				$ 0.001				$ 0.001		$ 0.001	$ 0.001
Preferred stock, shares issued					200,000	610,000			610,000				610,000				610,000		610,000	610,000
Preferred stock, shares outstanding						610,000			610,000				610,000				610,000		610,000	610,000
Shares issued																			200,000
Common stock, shares authorized						1,200,000,000			1,200,000,000				600,000,000				1,200,000,000		1,200,000,000	600,000,000
Common stock, par value						$ 0.001			$ 0.001				$ 0.001				$ 0.001		$ 0.001	$ 0.001
Common stock, shares issued						616,351,592	539,310,756	488,648,586	446,385,628				379,523,000				616,351,592		446,385,628	379,523,000
Common Stock, Shares, Outstanding						616,351,592	539,310,756	488,648,586	446,385,628				379,523,000				616,351,592		446,385,628	379,523,000
Capital stock, authorized															600,000,000
Preferred stock shares increased															0.001
Number of common stock sold						2,000,000	8,625,000	5,500,000	3,333,333	11,000,000	16,500,000	17,500,000	40,000,000	9,550,000	40,675,000	6,337,500
Number of common stock issued						77,040,836	50,662,170	42,262,958	3,333,333		16,500,000	17,500,000	12,000,000	3,500,000	825,000	6,337,500
Share price						$ 0.0141											$ 0.0141
Proceeds from sale of stock										$ 59,957,000	$ 82,455,000		$ 200,905,000	$ 66,500,000	$ 214,510,000	$ 133,495,000	$ 938,827	$ 219,822	$ 240,698	$ 576,803
Warrants expire									Jun. 8, 2022	Feb. 4, 2022	Dec. 21, 2022		Jun. 12, 2021	Mar. 12, 2022	Nov. 1, 2021	Sep. 17, 2021
Stock issued for stock payable						15,826,550	11,032,663	8,133,333	3,333,333	12,000,000	16,500,000	17,500,000	9,000,000	9,550,000	40,675,000	6,337,500
Number of stock converted						90,750	19,148,052	17,534,387
Warrants to purchase shares, description	(i) a promissory note in the aggregate principal amount of $250,000 (the “Note”), (ii) a common stock purchase warrant (the “Warrant”) to purchase up to an aggregate of 12,500,000 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and (iii) 12,500,000 shares of Common Stock (the “Commitment Shares”).	(5) common stock purchase warrants, respectively, for the purchase of (i) 500,000 shares of common stock (the “First Warrant”), (ii) 1,000,000 shares of common stock (the “Second Warrant”), (iii) 1,000,000 shares of common stock (the “Third Warrant”), (iv) 2,500,000 shares of common stock (the “Fourth Warrant”), and (v) 62,500,000 shares of the Company’s common stock (the “Fifth Warrant”) at the Exercise Price (as such term is defined in each of the Warrants) per share then in effect.				(i) 2,000,000 shares of common stock at a price of $0.70 per share and (ii) 1,000,000 shares of common stock at a price of $1.00 per share. The warrants expire at various times through February 9, 2023. None of the 2,000,000 shares of common stock were issued during the quarter ended March 31, 2022, and were recognized as stock payable.	(i) 8,625,000 shares of common stock at a price of $0.70 per share and (ii) 4,312,500 shares of common stock at a price of $1.00 per share. The warrants expire at various times through December 14, 2022. None of the 8,625,000 shares of common stock were issued during the quarter ended December 31, 2021, and were recognized as stock payable.	(i) 5,500,000 shares of common stock at a price of $0.10 per share and (ii) 5,500,000 shares of common stock at a price of $0.20 per share. The warrants expire at various times through September 21, 2022. None of the 12,000,000 shares of common stock were issued during the quarter ended September 30, 2021, and were recognized as stock payable.	(i) 3,333,333 shares at a price of $0.10 per share and (ii) 3,333,333 shares at a price of $0.20.	(i) 12,000,000 shares at a price of $0.10 per share and (ii) 12,000,000 shares at a price of $0.20.	(i) 16,500,000 shares at prices ranging from $0.05 to $0.10 per share and (ii) 16,500,000 shares at prices ranging from $0.10 to $0.20 and (iii) 1,500,000 at a price of $0.30.	(i) 17,500,000 shares at prices ranging from $0.05 per share to $0.10 per share and (ii) 14,500,000 shares at prices ranging from $0.10 to $0.20 for net proceeds of $77,409. The warrants expire at various times through September 21, 2022.
Shares issued for legal services												585,000
Warrants are vested									124,888,519										124,888,519
Class of warrants expire																	54,664,518		124,888,519
Description of Registration Statement			the Company shall have the discretion to deliver puts to GHS and GHS will be obligated to purchase shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”) based on the investment amount specified in each put notice. The maximum amount that the Company shall be entitled to put to GHS in each put notice shall not exceed two hundred percent (200%) of the average daily trading dollar volume of the Company’s Common Stock during the ten (10) trading days preceding the put, so long as such dollar amount does not exceed $500,000. Pursuant to the Equity Financing Agreement, GHS and its affiliates will not be permitted to purchase and the Company may not put shares of the Company’s Common Stock to GHS that would result in GHS’s beneficial ownership, equaling more than 4.99% of the Company’s outstanding Common Stock. The price of each put share shall be equal to eighty percent (80%) of the Market Price (as defined in the Equity Financing Agreement). Puts may be delivered by the Company to GHS until the earlier of thirty-six (36) months after the effectiveness of the Registration Statement.
Proceeds From Issuance Of Common Stocks						$ 19,980	$ 86,230	$ 27,462
Finders fee							12,500,000	12,500,000
Shares issued for legal services, amount						$ 25,000	$ 24,308	$ 36,000											$ 18,925
Registration statement description			Company shall have the discretion to deliver puts to GHS and GHS will be obligated to purchase shares of the Company’s Common Stock based on the investment amount specified in each put notice. The maximum amount that the Company shall be entitled to put to GHS in each put notice shall not exceed two hundred percent (200%) of the average daily trading dollar volume of the Company’s Common Stock during the ten (10) trading days preceding the put, so long as such dollar amount does not exceed $500,000. Pursuant to the Equity Financing Agreement, GHS and its affiliates will not be permitted to purchase and the Company may not put shares of the Company’s Common Stock to GHS that would result in GHS’s beneficial ownership, equaling more than 4.99% of the Company’s outstanding Common Stock. The price of each put share shall be equal to eighty percent (80%) of the Market Price (as defined in the Equity Financing Agreement). Puts may be delivered by the Company to GHS until the earlier of thirty-six (36) months after the effectiveness of the Registration Statement.
Class of warrants vested																	54,664,518
Convertible Promissory Note [Member]
Class of Stock [Line Items]
Principal balance (in Dollars)			$ 35,000
Interest rate, percentage			10.00%
Fixed conversion price (in Dollars per share)			$ 0.0175
Deferred financing costs (in Dollars)			$ 35,000
Securities Purchase Agreements [Member]
Class of Stock [Line Items]
Shares issued for legal services						57,500,000
Shares issued for legal services, amount						$ 783,000
Legal Sevices [Member]
Class of Stock [Line Items]
Shares issued for legal services							7,981,445
Convertible Promissory Note [Member]
Class of Stock [Line Items]
Principal balance (in Dollars)			$ 35,000,000
Interest rate, percentage			10.00%
Fixed conversion price (in Dollars per share)			$ 0.0175
Deferred financing costs (in Dollars)			$ 35,000,000
Common Stock [Member]
Class of Stock [Line Items]
Number of common stock issued															2,370,696				26,473,580
Shares issued for legal services						3,714,286	7,981,455	4,095,238											3,145,440
Shares issued for legal services, amount						$ 3,714	$ 7,981	$ 4,095											$ 3,145
Common Stock [Member] | Legal Sevices [Member]
Class of Stock [Line Items]
Shares issued for legal services								4,095,238
Minimum [Member]
Class of Stock [Line Items]
Share price													$ 0.10	$ 0.05	$ 0.20	$ 0.10				$ 0.10
Maximum [Member]
Class of Stock [Line Items]
Share price													$ 0.20	$ 1	$ 0.25	$ 0.25				$ 0.20
Series B Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized									5,000,000										5,000,000
Preferred stock, par value (in Dollars per share)									$ 0.001										$ 0.001
Preferred stock, shares issued				210,000					610,000										610,000
Preferred stock, shares outstanding									610,000										610,000
Preferred stock shares increased																						5,000,000
Stock issued						3,714,286	107,000	116,050
Series B Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized						5,000,000											5,000,000
Preferred stock, par value (in Dollars per share)						$ 0.001											$ 0.001
Preferred stock, shares issued						610,000											610,000
Preferred stock, shares outstanding						610,000											610,000
Preferred stock, stated value per share (in Dollars per share)									$ 5										$ 5
Preferred stock shares																							500,000
Number of shares issued				210,000	200,000												200,000
Common Class A [Member]
Class of Stock [Line Items]
Common stock, shares authorized									50,000,000										50,000,000
Common stock, par value									$ 0.001										$ 0.001
Common stock, shares issued									0										0
Common Stock, Shares, Outstanding									0										0
Series C Preferred Stock [Member]
Class of Stock [Line Items]
Number of stock converted									36,300						36,300		216,425	72,600	72,600	104,000
Preferred Stock [Member]
Class of Stock [Line Items]
Number of common stock issued											78,100	6,032,260
Number of stock converted										72,600		5,447,260
Common Stock [Member]
Class of Stock [Line Items]
Number of common stock issued									3,025,952	26,769,540	32,034,876
Proceeds from sale of stock											$ 75,000,000
Stock issued for stock payable										17,000,000	15,000,000
Number of stock converted										6,709,100	16,034,876
Shares issued for legal services										2,560,440
Series C Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized																					1,000,000
Preferred stock, par value (in Dollars per share)																					$ 0.001
Preferred stock, shares issued						103,584			196,083								103,584		196,083
Preferred stock, shares outstanding						103,584			196,083								103,584		196,083

MANDATORY REDEEMABLE CONVERTI_2

MANDATORY REDEEMABLE CONVERTIBLE PREFERRED STOCK (Details Narrative) - USD ($)	Jan. 14, 2019	Mar. 31, 2022	Jun. 30, 2021	Jun. 30, 2020	Oct. 31, 2015
Preferred stock, authorized (in Shares)		5,000,000	5,000,000	5,000,000
Preferred stock, par value (in Dollars per share)		$ 0.001	$ 0.001	$ 0.001
Preferred Stock, Shares Issued		610,000	610,000	610,000	200,000
Preferred Stock, Shares Outstanding		610,000	610,000	610,000
Preferred shares convertible average market price rate		71.00%	71.00%
Preferred stock dividends			$ 163,575	$ 32,024
Accrued dividends payable		$ 10,589	$ 2,442	$ 2,945
Amortized utilizing effective interest discount amount (in Dollars)		$ 35,000
Series C Convertible Preferred Stock [Member]
Preferred stock, authorized (in Shares)	1,000,000
Preferred stock, par value (in Dollars per share)	$ 0.001
Dividend percent	10.00%
Preferred Stock, Shares Issued		103,584	196,083
Preferred Stock, Shares Outstanding		103,584	196,083
Fair value of convertible preferred stock (in Dollars)		$ 103,584	$ 196,083
Preferred shares, description		There were 48,125 shares of Series C Preferred Stock issued for net proceeds of $40,000, and 90,750 shares of Series C Preferred Stock converted to 15,826,550 shares of common stock for the three months ended March 31, 2022.
Series C Convertible Preferred Stock [Member] | Minimum [Member]
Dividend percent	105.00%
Series C Convertible Preferred Stock [Member] | Maximum [Member]
Dividend percent	130.00%
Series C Mandatory Redeemable Convertible Preferred Stocks [Member]
Preferred stock, authorized (in Shares)			1,000,000	1,000,000
Dividend percent	10.00%
Preferred Stock, Shares Issued			239,025	117,200
Preferred Stock, Shares Outstanding			239,025	117,200
Description of conversion of stock			The Holder shall have the right at any time during the period beginning on the date which is six (6) months following the Issuance Date, to convert all or any part of the outstanding Series C Preferred Stock into fully paid and non-assessable shares of Common Stock at the Variable Conversion Price. The “Variable Conversion Price” shall mean 71% multiplied by the Market Price (representing a discount rate of 29%). “Market Price” means the average of the two (2) lowest Trading Prices (as defined here) for the Common Stock during the fifteen (15) Trading Day period ending on the latest complete Trading Day prior to the Conversion Date.
Fair value of convertible preferred stock (in Dollars)			$ 196,083	$ 101,661
Estimated fair value of convertible preferred stock			$ 196,083	$ 101,661
Series C Mandatory Redeemable Convertible Preferred Stocks [Member] | Minimum [Member]
Dividend percent	105.00%
Series C Mandatory Redeemable Convertible Preferred Stocks [Member] | Maximum [Member]
Dividend percent	130.00%
Series C Convertible Preferred Stocks [Member]
Preferred Stock, Shares Issued		103,584	196,084
Preferred Stock, Shares Outstanding		103,584	196,084

Income Taxes (Details)

Income Taxes (Details) - USD ($)	Jun. 30, 2021	Jun. 30, 2020
Income Tax Disclosure [Abstract]
Net operating loss carryforward	$ 9,789,107	$ 8,983,161
Warrant issuances
Deferred officer compensation	737,642	805,848
Other	0	98
Valuation allowance	(10,526,749)	(9,789,107)
Deferred Tax Assets, Net

Income Taxes (Details 1)

Income Taxes (Details 1)	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2021	Jun. 30, 2020
Income Tax Disclosure [Abstract]
Tax on income before income tax		21.00%	21.00%
Effect of non-temporary differences		(0.01%)	(0.01%)
Effect of prior year items
Effect of temporary differences
Change in valuation allowance		(20.99%)	(20.99%)
Effective Income Tax Rate Reconciliation, Percent	0.00%	0.00%	0.00%

INCOME TAXES (Details Narrative

INCOME TAXES (Details Narrative) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2021	Jun. 30, 2020
Income Tax Disclosure [Abstract]
Operating loss carryforwards, limitations on use		Company had a net operating loss carry-forwards in the amount of approximately $28.9 million available to offset future taxable income through 2038.
Operating loss carryforwards		$ 28,900
Taxable income, percentage		80.00%
Income tax examination, description		The Company remains subject to U.S. federal examination for tax years ended 2017, 2018, 2019, 2020 and 2021.
Effective income tax rate reconciliation, percentage	0.00%	0.00%	0.00%

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - USD ($)	3 Months Ended										12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2021
Issue of common shares	77,040,836	50,662,170	42,262,958	3,333,333	16,500,000	17,500,000	12,000,000	3,500,000	825,000	6,337,500
Preferred shares converted				51,850							51,850
Common stock converted											5,940,247
Preferred Stock [Member]
Preferred shares issued				48,125							48,125
Cash received (in Dollars)											$ 43,745
Common Stock [Member]
Issue of common shares									2,370,696		26,473,580

STOCKHOLDERS' DEFICIT (Details)

STOCKHOLDERS' DEFICIT (Details) - $ / shares	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2021	Jun. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Number of Warrants Outstanding (in Shares)	54,664,518	124,888,519	53,280,406
Weighted-Average Contractual Life Remaining in Years	1 year 2 months 12 days	1 year 1 month 13 days	1 year 1 month 13 days
Weighted- Average Exercise Price	$ 0.26	$ 0.33	$ 0.33
Number Exercisable (in Shares)	54,664,518	124,888,519	53,280,406
Weighted- Average Exercise Price	$ 0.26	$ 0.33	$ 0.33

STOCKHOLDERS' DEFICIT (Details

STOCKHOLDERS' DEFICIT (Details 1) - shares	9 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Jun. 30, 2021	Jun. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Outstanding - beginning of year	124,888,519	53,280,406	53,280,406	26,526,234
Issued	22,937,499	90,500,000	98,500,000	34,662,500
Exercised
Expired	(93,161,500)	(17,151,887)	(26,891,887)	(7,908,328)
Outstanding - end of year	54,664,518	126,628,519	124,888,519	53,280,406

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)	Sep. 11, 2017	Mar. 31, 2022	Mar. 31, 2021	Jun. 30, 2021	Jun. 30, 2020
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Rent expense		$ 1,537	$ 1,590
Accrued the amounts		753,475		$ 744,115
Interest Payable		240,712		188,686	$ 149,481
Annual salary		$ 190,000		$ 190,000
Chief Executive Officer [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Related party transactions, description	(i) 200,000 shares of Series B Convertible Preferred Stock, (ii) a royalty equal to 5% of gross revenues derived from products sold related to the patents, and (iii) certain minimum required payments beginning at $50,000 and doubling each year thereafter. The Series B Preferred Stock may be converted at the election of holder on a basis for 50 common shares for each preferred share at any time or an aggregate of 10,000,000 common shares in exchange for all 200,000 shares of Series B Convertible Preferred Stock.

DERIVATIVE LIABILITIES (Details

DERIVATIVE LIABILITIES (Details) - USD ($)	Mar. 31, 2022	Jun. 30, 2021	Jun. 30, 2020
Defined Benefit Plan Disclosure [Line Items]
Derivative liability	$ 155,973	$ 45,524
Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Derivative liability
Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Derivative liability
Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Derivative liability	$ 155,973

DERIVATIVE LIABILITIES (Detai_2

DERIVATIVE LIABILITIES (Details Narrative)	9 Months Ended
	Mar. 31, 2022$ / shares
Derivative Liabilities
Share Price	$ 0.0141
Risk free rate, Minimum	0.10%
Risk free rate, Maximum	0.11%
Volatility rate, Minimum	150.00%
Volatility rate, Maximum	341.00%